Impax releases generic version of dutasteride capsules, 0.5 mg

November 24, 2015

Impax Laboratories, Inc. today announced that on November 20, the Company's development and manufacturing partner received final approval by the U.S. Food and Drug Administration for a generic version of dutasteride capsules, 0.5 mg.

Previous Article
Teledyne DALSA's CMOS X-Ray detector for mammography to be introduced at RSNA 2015 Technical Exhibition
Teledyne DALSA's CMOS X-Ray detector for mammography to be introduced at RSNA 2015 Technical Exhibition

Teledyne DALSA, a Teledyne Technologies company and global leader in digital X-Ray image sensing technology...

Next Article
Catasys to provide assistance to Humana members experiencing substance abuse challenges
Catasys to provide assistance to Humana members experiencing substance abuse challenges

Catasys, Inc., a provider of proprietary big-data based analytics and predictive modeling driven health man...